Enpiprazole (INN, BAN) is an anxiolytic drug of the phenylpiperazine group that was never marketed.[1][2] It produces anxiolytic-like effects in animals, though these effects appear to be biphasic and may reverse at high doses.[3] It is known to produce ortho-chlorophenylpiperazine (oCPP) as a metabolite.[4]
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H21ClN4 |
Molar mass | 304.82 g·mol−1 |
3D model (JSmol) | |
|
See also
editReferences
edit- ^ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 488–. ISBN 978-1-4757-2085-3.
- ^ Bernan, British Pharmacopoeia Commission (2002). British Approved Names 2002. United Kingdom: The Stationery Office. p. 359. ISBN 0-11-322558-X.
- ^ Murasaki M, Hara T, Oguchi T, Inami M, Ikeda Y (September 1976). "Action of enpiprazole on emotional behavior induced by hypothalamic stimulation in rats and cats". Psychopharmacology. 49 (3): 271–4. doi:10.1007/BF00426829. PMID 12526. S2CID 10302402.
- ^ B.L. Goodwin (10 November 2004). Handbook of Biotransformations of Aromatic Compounds. CRC Press. pp. 3–. ISBN 978-0-203-64196-5.